News

At the conclusion of the inspection, the FDA issued a Form 483 with seven inspectional observations, two of which are designated as repeat observations. The FDA did not

The company is working with GlaxoSmithKline to ensure sufficient supply to meet anticipated demand. The company and its lenders are also performing additional due diligence related to this

As part of the deal, Roche will make an upfront cash payment of $250m to Santaris shareholders and make additional contingent payments of up to $200m based on

By joining The US Oncology Network, the physicians at Optim Oncology and Urology Centers of Oklahoma can collaborate with other oncology experts from across the nation in real

RXDX-103 is an inhibitor of the cell division cycle 7-related (Cdc7) protein kinase, and RXDX-104 is a program to identify a highly selective inhibitor of the rearranged during

In exchange for a one-time, upfront payment of $5.0 million, Infinity receives an option to terminate its obligation to pay Millennium future royalties related to the sale of

The acquisition will include the Intellectual Properties ("IP"), assets and talents of this cancer-therapy-focused developmental stage company. The IP is comprised of T Cells Receptor ("TCR") clonality analysis

The deal provides toxicity and efficacy studies of cannabinoid formulations carried out in animal models for neurobehavioral diseases including sleep disorders. The company said that the first formulation

In the trial, dosing of the first infant will be carried out within the next few weeks, when Isis will receive an $18m milestone payment from its development